B cell depletion by anti-CD20 antibodies entrains trabecular bone loss in mice

被引：0
|
作者：
Kolomansky, A. [1 ,2 ]
Deshet-Unger, N. [1 ,2 ]
Ostrovsky, A. [1 ,2 ]
Hiram-Bab, S. [1 ,3 ]
Ben-Califa, N. [1 ,2 ]
Liron, T. [1 ,3 ]
Oster, H. S. [1 ,4 ]
Mittelman, M. [1 ,4 ]
Gabet, Y. [1 ,3 ]
Neumann, D. [1 ,2 ]
机构：
[1] Tel Aviv Univ, Tel Aviv, Israel
[2] Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel
[3] Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel
[4] Sourasky Med Ctr, Tel Aviv, Israel
来源：
FEBS JOURNAL | 2017年 / 284卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P.1.5-064
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] B cell depletion by anti-CD20 antibodies entrains trabecular bone loss in mice.
    Kolomansky, Albert
    Deshet-Unger, Naamit
    Ostrovsky, Alina
    Hiram-Bab, Sahar
    Ben-Califa, Nathalie
    Liron, Tamar
    Oster, Howard S.
    Mittelman, Moshe
    Gabet, Yankel
    Neumann, Drorit
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S310 - S310
  • [2] Pharmacological B Cell Depletion by Anti-CD20 Antibody Induces Trabecular Bone Loss in Mice
    Kolomansky, Albert
    Deshet-Unger, Naamit
    Ostrovsky, Alina
    Ben-Califa, Nathalie
    Hiram-Bab, Sahar
    Liron, Tamar
    Oster, Howard
    Mittelman, Moshe
    Gabet, Yankel
    Neumann, Drorit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S377 - S378
  • [3] Role of the IGG backbone in B cell depletion and inhibitor reversal in hemophilia A WITH anti-CD20 antibodies
    Rogers, G. L.
    Sherman, A.
    Markusic, D.
    Jiang, H.
    Herzog, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 134 - 135
  • [4] B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
    Leandro, Maria J.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [5] Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
    Roll, Petra
    Palanichamy, Arumugam
    Kneitz, Christian
    Dorner, Thomas
    Tony, Hans-Peter
    ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2377 - 2386
  • [6] B cell depletion with Anti-CD20 delays and reverses murine lupus
    Bekar, Kai
    Owen, Teresa
    Dunn, Robert
    Kehry, Marilyn R.
    Anolik, Jennifer H.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S315 - S315
  • [7] B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans
    Wang, Angela A.
    Luessi, Felix
    Neziraj, Tradite
    Possnecker, Elisabeth
    Zuo, Michelle
    Engel, Sinah
    Hanuscheck, Nicholas
    Florescu, Alexandra
    Bugbee, Eryn
    Ma, Xianjie I.
    Rana, Fatima
    Lee, Dennis
    Ward, Lesley A.
    Kuhle, Jens
    Himbert, Johannes
    Schraad, Muriel
    van Puijenbroek, Erwin
    Klein, Christian
    Urich, Eduard
    Ramaglia, Valeria
    Probstel, Anne-Katrin
    Zipp, Frauke
    Gommerman, Jennifer L.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (737)
  • [8] Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion
    Bockenstedt, Marie M.
    Boggiatto, Paola M.
    Jones, Douglas E.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6192 - 6202
  • [9] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
  • [10] Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
    Okroj, Marcin
    Osterborg, Anders
    Blom, Anna M.
    CANCER TREATMENT REVIEWS, 2013, 39 (06) : 632 - 639
12345